Physician profile
John Patrick Walsh
NPI 1740854439
$4,065.36
in general payments reported to CMS, 2019-2025
18 companies · $1,847 in 2025
The $1,847 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $298 · 2022: $550 · 2023: $293 · 2024: $1,077 · 2025: $1,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,056 · Travel and Lodging: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,055.56 |
| Travel and Lodging | $1,161.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,117.07 | 2022-2025 | Real Intelligence, Journey II, Polarcup |
| Stryker Corporation | $1,084.32 | 2024-2025 | Pro, Mako, Axsos |
| Integra Lifesciences Corporation | $365.95 | 2021-2024 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Kerecis Limited | $331.34 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Goode Surgical INC | $265.87 | 2021-2024 | |
| Medical Device Business Services, INC. | $219.14 | 2022 | |
| Orthofix Medical, INC. | $211.26 | 2025 | Accelstim, Physio-Stim |
| Davol INC. | $125.78 | 2021 | |
| Endo Pharmaceuticals INC. | $124.14 | 2022 | |
| Acera Surgical, INC. | $42.65 | 2021 | |
| Abbvie INC. | $30.97 | 2021 | |
| Axogen | $29.44 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Bioventus LLC | $23.31 | 2021 | |
| Si-Bone, INC. | $21.35 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.31 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $18.44 | 2023 | Teligen |
| Pacira Pharmaceuticals Incorporated | $17.10 | 2025 | Exparel |
| Ethicon US, LLC | $15.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.